Sub-Bowman's keratomileusis (SBK) is associated with a low complication rate.
Alzheimer disease retinopathy and brain-to-eye β-amyloid transport
The research findings highlighted a new therapeutic avenue in ocular and neurodegenerative disease
Higher Molar Dose and Its Translation into Clinical Practice
What's missing in patient education?
A different approach better serves patients with diabetic retinopathy
Novaliq and Laboratoires Théa announce European Commission approval of ciclosporin 0.1% eye drops solution
Ciclosporin 0.1% eye drops solution will be marketed under the brand name Vevizye in the EU for the treatment of dry eye disease
Novel therapies emerge for a progressive corneal disease
Current and future options for Fuchs endothelial corneal dystrophy
The latest genetic research from this summer’s retina conferences
Gene therapy was a major topic at the 2024 EURETINA and Retina Society meetings
